GB/T 16886.2-2011
Biological evaluation of medical devices.Part 2: Animal welfare requirements (English Version)

Standard No.
GB/T 16886.2-2011
Language
Chinese, Available in English version
Release Date
2011
Published By
General Administration of Quality Supervision, Inspection and Quarantine of the People‘s Republic of China
Latest
GB/T 16886.2-2011
Replace
GB/T 16886.2-2000
Scope
This part of GB/T 16886 applies to the process of entrusting, designing and conducting tests or evaluating animal test data to evaluate the biocompatibility of materials or devices used in medical devices. This section specifies the most basic requirements to ensure the welfare of animals used in animal tests for the evaluation of biocompatibility of medical device materials through the corresponding regulations, and form a document. This section also gives suggestions and guidelines to further reduce the overall number of animals, optimize test methods to reduce or eliminate animal pain or suffering, and use other scientifically valid methods that do not require animal testing to replace animal testing. This section applies to tests on live vertebrates other than humans, which are used to determine the biocompatibility of materials or medical devices. This section does not apply to tests conducted on invertebrates and other animals with a lower degree of differentiation, nor does it apply to tests conducted on isolated tissues and organs of vertebrates that have been humanely sacrificed (except for animal species, sources , health status, feeding and management regulations).

GB/T 16886.2-2011 Referenced Document

  • ISO 10993-1 Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process*2018-08-01 Update

GB/T 16886.2-2011 history

  • 2011 GB/T 16886.2-2011 Biological evaluation of medical devices.Part 2: Animal welfare requirements
  • 2000 GB/T 16886.2-2000 Biological evaluation of medical devices--Part 2: Animal welfare requirements
Biological evaluation of medical devices.Part 2: Animal welfare requirements

GB/T 16886.2-2011 -All Parts

GB/T 16886.1-2022 Biological evaluation of medical devices—Part 1: Evaluation and testing within a risk management process GB/T 16886.10-2017 Biological evaluation of medical devices—Part 10: Tests for irritation and skin sensitization GB/T 16886.11-2021 Biological evaluation of medical devices—Part 11: Tests for systemic toxicity GB/T 16886.12-2023 Biological Evaluation of Medical Devices Part 12: Sample Preparation and Reference Materials GB/T 16886.13-2017 Biological evaluation of medical devices—Part 13: Identification and quantification of degradation products from polymeric medical devices GB/T 16886.14-2003 Biological evaluation of medical devices--Part 14: Identification and quantification of degradation products from ceramics GB/T 16886.15-2022 Biological evaluation of medical devices—Part 15: Identification and quantification of degradation products from metals and alloys GB/T 16886.16-2021 Biological evaluation of medical devices—Part 16: Toxicokinetic study design for degradation products and leachables GB/T 16886.17-2005 Biological evaluation of medical devices.Part 17:Establishment of allowable limits for leachable substances GB/T 16886.18-2022 Biological evaluation of medical devices—Part 18: Chemical characterization of medical device materials within a risk management process GB/T 16886.19-2022 Biological evaluation of medical devices—Part 19: Physico-chemical, morphological and topographical characterization of materials GB/T 16886.2-2011 Biological evaluation of medical devices.Part 2: Animal welfare requirements GB/T 16886.20-2015 Biological evaluation of medical devices.Part 20:Principles and methods for immunotoxicology testing of medical devices GB/T 16886.23-2023 Biological Evaluation of Medical Devices Part 23: Stimulation Test GB/T 16886.3-2019 Biological evaluation of medical devices—Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity GB/T 16886.4-2022 Biological evaluation of medical devices—Part 4: Selection of tests for interactions with blood GB/T 16886.5-2017 Biological Evaluation of Medical Devices Part 5: In Vitro Cytotoxicity Tests GB/T 16886.6-2022 Biological evaluation of medical devices—Part 6:Tests for local effects after implantation GB/T 16886.7-2015 Biological evaluation of medical devices—Part 7: Ethylene oxide sterilization residuals GB/T 16886.9-2022 Biological Evaluation of Medical Devices Part 9: Qualitative and Quantitative Framework for Potential Degradation Products



Copyright ©2024 All Rights Reserved